Should every survivor of a heart attack be given a beta blocker? Part II. Evidence from a clinical pharmacological standpoint.
- 3 July 1982
- Vol. 285 (6334) , 37-39
- https://doi.org/10.1136/bmj.285.6334.37
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Jogger's blockade.BMJ, 1982
- HIGH PLASMA CONCENTRATIONS OF β-RECEPTOR BLOCKING DRUGS AND DEFICIENT DEBRISOQUINE HYDROXYLATIONThe Lancet, 1982
- One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.BMJ, 1982
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Abrupt Withdrawal of Cardiovascular DrugsNew England Journal of Medicine, 1979
- Prognostic Value of Exercise Testing Soon after Myocardial InfarctionNew England Journal of Medicine, 1979
- Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.BMJ, 1979
- The course of acute myocardial infarction. Feasibility of early discharge of the uncomplicated patient.Circulation, 1975
- Propranolol in the therapy of angina pectorisThe American Journal of Cardiology, 1966